• 1

    JemalASiegelRXuJWardE. Cancer statistics, 2010. CA Cancer J Clin2010;60:277300.

  • 2

    AltekruseSFKosaryCLKrapchoM. eds. SEER Cancer Statistics Review 1975–2007: National Cancer Institute. Bethesda, MDbased on November 2009 SEER data submission posted to the SEER web site2010. Available at: http://seer.cancer.gov/csr/1975_2007/. Accessed January 12 2012.

    • Search Google Scholar
    • Export Citation
  • 3

    SmithBDSmithGLHurriaA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol2009;27:27582765.

    • Search Google Scholar
    • Export Citation
  • 4

    BalducciLBegheC. Cancer and age in the USA. Crit Rev Oncol Hematol2001;37:137145.

  • 5

    TalaricoLChenGPazdurR. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol2004;22:46264631.

    • Search Google Scholar
    • Export Citation
  • 6

    SaltzsteinSLBehlingCA. 5- and 10-year survival in cancer patients aged 90 and older: a study of 37,318 patients from SEER. J Surg Oncol2002;81:113116; dicussion 117.

    • Search Google Scholar
    • Export Citation
  • 7

    ExtermannM. Management issues for elderly patients with breast cancer. Curr Treat Options Oncol2004;5:161169.

  • 8

    ChenHCantorAMeyerJ. Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer2003;97:11071114.

  • 9

    ChristmanKMussHBCaseLDStanleyV. Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment]. JAMA1992;268:5762.

    • Search Google Scholar
    • Export Citation
  • 10

    SargentDJGoldbergRMJacobsonSD. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med2001;345:10911097.

    • Search Google Scholar
    • Export Citation
  • 11

    BalducciL. Management of cancer in the elderly. Oncology (Williston Park)2006;20:135143.

  • 12

    WeddingUHoneckerFBokemeyerC. Tolerance to chemotherapy in elderly patients with cancer. Cancer Control2007;14:4456.

  • 13

    WalterLCCovinskyKE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA2001;285:27502756.

  • 14

    LeeSJLindquistKSegalMRCovinskyKE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA2006;295:801808.

    • Search Google Scholar
    • Export Citation
  • 15

    CareyECWalterLCLindquistKCovinskyKE. Development and validation of a functional morbidity index to predict mortality in community-dwelling elders. J Gen Intern Med2004;19:10271033.

    • Search Google Scholar
    • Export Citation
  • 16

    StudenskiSPereraSPatelK. Gait speed and survival in older adults. JAMA2011;305:5058.

  • 17

    ExtermannMHurriaA. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol2007;25:18241831.

  • 18

    PalSKKatheriaVHurriaA. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin2010;60:120132.

    • Search Google Scholar
    • Export Citation
  • 19

    RodinMBMohileSG. A practical approach to geriatric assessment in oncology. J Clin Oncol2007;25:19361944.

  • 20

    BalducciLExtermannM. Management of cancer in the older person: a practical approach. Oncologist2000;5:224237.

  • 21

    IngramSSSeoPHMartellRE. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol2002;20:770775.

    • Search Google Scholar
    • Export Citation
  • 22

    RepettoLFratinoLAudisioRA. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol2002;20:494502.

    • Search Google Scholar
    • Export Citation
  • 23

    MaionePPerroneFGalloC. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol2005;23:68656872.

    • Search Google Scholar
    • Export Citation
  • 24

    KoroukianSMXuFBakakiPM. Comorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer. J Gerontol A Biol Sci Med Sci2010;65:322329.

    • Search Google Scholar
    • Export Citation
  • 25

    WinkelmannNPetersenIKiehntopfM. Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma. J Cancer Res Clin Oncol2011;137:733738.

    • Search Google Scholar
    • Export Citation
  • 26

    Clough-GorrKMThwinSSStuckAESillimanRA. Examining five- and ten-year survival in older women with breast cancer using cancer-specific geriatric assessment. Eur J Cancer2011; July7[Epub ahead of print].

    • Search Google Scholar
    • Export Citation
  • 27

    CailletPCanoui-PoitrineFVouriotJ. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA Study. J Clin Oncol2011;29:36363642.

    • Search Google Scholar
    • Export Citation
  • 28

    HurriaAGuptaSZaudererM. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer2005;104:19982005.

  • 29

    HurriaAMohileSLichtmanS. Geriatric assessment of older adults with cancer: baseline data from a 500 patient multicenter study [abstract]. J Clin Oncol2009;27(Suppl 15):Abstract 9546.

    • Search Google Scholar
    • Export Citation
  • 30

    HurriaACirrincioneCTMussHB. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol2011:12901296.

    • Search Google Scholar
    • Export Citation
  • 31

    OvercashJABecksteadJExtermannMCobbS. The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol2005;54:129136.

    • Search Google Scholar
    • Export Citation
  • 32

    OvercashJABecksteadJMoodyL. The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation. Crit Rev Oncol Hematol2006;59:205210.

    • Search Google Scholar
    • Export Citation
  • 33

    KatzSFordABMoskowitzRW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA1963;185:914919.

    • Search Google Scholar
    • Export Citation
  • 34

    LawtonMP. Scales to measure competence in everyday activities. Psychopharmacol Bull1988;24:609614.

  • 35

    FreyerGGeayJFTouzetS. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol2005;16:17951800.

    • Search Google Scholar
    • Export Citation
  • 36

    LachsMSFeinsteinARCooneyLM. A simple procedure for general screening for functional disability in elderly patients. Ann Intern Med1990;112:699706.

    • Search Google Scholar
    • Export Citation
  • 37

    SalibaDElliottMRubensteinLZ. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc2001;49:16911699.

    • Search Google Scholar
    • Export Citation
  • 38

    MinLYoonWMarianoJ. The vulnerable elders-13 survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients. J Am Geriatr Soc2009;57:20702076.

    • Search Google Scholar
    • Export Citation
  • 39

    LucianiAAscioneGBertuzziC. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol2010;28:20462050.

    • Search Google Scholar
    • Export Citation
  • 40

    CohenHJHarrisTPieperCF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med2003;114:180187.

    • Search Google Scholar
    • Export Citation
  • 41

    TaaffeDRHarrisTBFerrucciL. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci2000;55:M709715.

    • Search Google Scholar
    • Export Citation
  • 42

    WilsonCJCohenHJPieperCF. Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons. J Am Geriatr Soc2003;51:13741381.

    • Search Google Scholar
    • Export Citation
  • 43

    ExtermannM. Interaction between comorbidity and cancer. Cancer Control2007;14:1322.

  • 44

    PalSKHurriaA. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol2010;28:40864093.

  • 45

    NandaAChenMHBraccioforteMH. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction. JAMA2009;302:866873.

    • Search Google Scholar
    • Export Citation
  • 46

    MeyerhardtJACatalanoPJHallerDG. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol2003;21:433440.

  • 47

    SrokowskiTPFangSHortobagyiGNGiordanoSH. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol2009;27:21702176.

    • Search Google Scholar
    • Export Citation
  • 48

    PiccirilloJFTierneyRMCostasI. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA2004;291:24412447.

  • 49

    CharlsonMEPompeiPAlesKLMacKenzieCR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis1987;40:373383.

    • Search Google Scholar
    • Export Citation
  • 50

    LinnBSLinnMWGurelL. Cumulative illness rating scale. J Am Geriatr Soc1968;16:622626.

  • 51

    FillenbaumGGSmyerMA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol1981;36:428434.

    • Search Google Scholar
    • Export Citation
  • 52

    BrecciaMLatagliataRStagnoF. Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib. Haematologica2011;96:14571461.

    • Search Google Scholar
    • Export Citation
  • 53

    SanabriaACarvalhoALMeloRL. Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck2008;30:170177.

    • Search Google Scholar
    • Export Citation
  • 54

    FrasciGLorussoVPanzaN. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol2000;18:25292536.

    • Search Google Scholar
    • Export Citation
  • 55

    HurriaABroganKPanageasKS. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat2005;92:151156.

    • Search Google Scholar
    • Export Citation
  • 56

    FaderANvon GruenigenVGibbonsH. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients. Gynecol Oncol2008;109:3338.

    • Search Google Scholar
    • Export Citation
  • 57

    GronbergBHSundstromSKaasaS. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer2010;46:22252234.

    • Search Google Scholar
    • Export Citation
  • 58

    NgeowJLeongSSGaoF. Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status. Crit Rev Oncol Hematol2010;76:5360.

    • Search Google Scholar
    • Export Citation
  • 59

    SanabriaACarvalhoALVartanianJG. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol2007;14:14491457.

    • Search Google Scholar
    • Export Citation
  • 60

    Tam-McDevittJ. Polypharmacy, aging, and cancer. Oncology (Williston Park)2008;22:10521055discussion 1055 1058 1060.

  • 61

    MaggioreRJGrossCPHurriaA. Polypharmacy in older adults with cancer. Oncologist2010;15:507522.

  • 62

    SokolKCKnudsenJFLiMM. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther2007;32:169175.

    • Search Google Scholar
    • Export Citation
  • 63

    PutsMTCosta-LimaBMonetteJ. Medication problems in older, newly diagnosed cancer patients in Canada: how common are they? A prospective pilot study. Drugs Aging2009;26:519536.

    • Search Google Scholar
    • Export Citation
  • 64

    LeesJChanA. Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol2011;12:12491257.

  • 65

    RiechelmannRPSaadED. A systematic review on drug interactions in oncology. Cancer Invest2006;24:704712.

  • 66

    RiechelmannRPTannockIFWangL. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst2007;99:592600.

    • Search Google Scholar
    • Export Citation
  • 67

    RiechelmannRPZimmermannCChinSN. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage2008;35:535543.

    • Search Google Scholar
    • Export Citation
  • 68

    PopaMWallaceKBrunelloAExtermannM. The impact of polypharmacy on toxicity from chemotherapy in elderly patients: focus on cytochrome P-450 inhibition and protein binding effects [abstract]. J Clin Oncol2008;26(Suppl 15):Abstract 9505.

    • Search Google Scholar
    • Export Citation
  • 69

    SteinmanMALandefeldSCRosenthalGE. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc2006;54:15161523.

  • 70

    CurrowDCStevensonJPAbernethyAP. Prescribing in palliative care as death approaches. J Am Geriatr Soc2007;55:590595.

  • 71

    MaggioreRJGrossCPHardtM. Polypharmacy, potentially inappropriate medications, and chemotherapy-related adverse events among older adults with cancer [abstract]. J Clin Oncol2011;29(Supp 1):Abstract e19501.

    • Search Google Scholar
    • Export Citation
  • 72

    BeersMH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med1997;157:15311536.

    • Search Google Scholar
    • Export Citation
  • 73

    FickDMCooperJWWadeWE. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med2003;163:27162724.

    • Search Google Scholar
    • Export Citation
  • 74

    FloodKLCarrollMBLeCVBrownCJ. Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit. Am J Geriatr Pharmacother2009;7:151158.

    • Search Google Scholar
    • Export Citation
  • 75

    LichtmanSMBoparaiMK. Geriatric medication management: evaluation of pharmacist interventions and potentially inappropriate medication (PIM) use in older (>=65 years) cancer patients [asbtract]. J Clin Oncol2009;27(Suppl):Abstract 9507.

    • Search Google Scholar
    • Export Citation
  • 76

    HanlonJTSchmaderKESamsaGP. A method for assessing drug therapy appropriateness. J Clin Epidemiol1992;45:10451051.

  • 77

    SamsaGPHanlonJTSchmaderKE. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol1994;47:891896.

    • Search Google Scholar
    • Export Citation
  • 78

    SchmaderKHanlonJTWeinbergerM. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc1994;42:12411247.

    • Search Google Scholar
    • Export Citation
  • 79

    KassamRMartinLGFarrisKB. Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother2003;37:4046.

    • Search Google Scholar
    • Export Citation
  • 80

    HanlonJTArtzMBPieperCF. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother2004;38:914.

  • 81

    GallagherPBaeyensJPTopinkovaE. Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing2009;38:603606.

    • Search Google Scholar
    • Export Citation
  • 82

    GallagherPO’MahonyD. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing2008;37:673679.

    • Search Google Scholar
    • Export Citation
  • 83

    BarryPJGallagherPRyanCO’MahonyD. START (screening tool to alert doctors to the right treatment)—an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing2007;36:632638.

    • Search Google Scholar
    • Export Citation
  • 84

    GallagherPFO’ConnorMNO’MahonyD. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther2011;89:845854.

    • Search Google Scholar
    • Export Citation
  • 85

    GuigozYLauqueSVellasBJ. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med2002;18:737757.

    • Search Google Scholar
    • Export Citation
  • 86

    VellasBGuigozYGarryPJ. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition1999;15:116122.

    • Search Google Scholar
    • Export Citation
  • 87

    RubensteinLZHarkerJOSalvaA. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci2001;56:M366372.

    • Search Google Scholar
    • Export Citation
  • 88

    BjorkmanMPSorvaAJRisteliJTilvisRS. Low parathyroid hormone levels in bedridden geriatric patients with vitamin D deficiency. J Am Geriatr Soc2009;57:10451050.

    • Search Google Scholar
    • Export Citation
  • 89

    StilleyCSBenderCMDunbar-JacobJ. The impact of cognitive function on medication management: three studies. Health Psychol2010;29:5055.

    • Search Google Scholar
    • Export Citation
  • 90

    ExtermannM. Older patients, cognitive impairment, and cancer: an increasingly frequent triad. J Natl Compr Canc Netw2005;3:593596.

  • 91

    ChewMLMulsantBHPollockBG. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc2008;56:13331341.

    • Search Google Scholar
    • Export Citation
  • 92

    HilmerSNMagerDESimonsickEM. A drug burden index to define the functional burden of medications in older people. Arch Intern Med2007;167:781787.

    • Search Google Scholar
    • Export Citation
  • 93

    NaeimAReubenD. Geriatric syndromes and assessment in older cancer patients. Oncology (Williston Park)2001;15:15671577.

  • 94

    SeemanTEKaplanGAKnudsenL. Social network ties and mortality among the elderly in the Alameda County Study. Am J Epidemiol1987;126:714723.

    • Search Google Scholar
    • Export Citation
  • 95

    TomakaJThompsonSPalaciosR. The relation of social isolation, loneliness, and social support to disease outcomes among the elderly. J Aging Health2006;18:359384.

    • Search Google Scholar
    • Export Citation
  • 96

    KroenkeCHKubzanskyLDSchernhammerES. Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol2006;24:11051111.

    • Search Google Scholar
    • Export Citation
  • 97

    FloodKLCarrollMBLeCV. Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J Clin Oncol2006;24:22982303.

    • Search Google Scholar
    • Export Citation
  • 98

    MohileSGFanLReeveE. Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol2011;29:14581464.

  • 99

    GuptaSKLamontEB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc2004;52:16811687.

    • Search Google Scholar
    • Export Citation
  • 100

    RajiMAKuoYFFreemanJLGoodwinJS. Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care. Arch Intern Med2008;168:20332040.

    • Search Google Scholar
    • Export Citation
  • 101

    CrumRMAnthonyJCBassettSSFolsteinMF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA1993;269:23862391.

    • Search Google Scholar
    • Export Citation
  • 102

    TombaughTNMcIntyreNJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc1992;40:922935.

  • 103

    KawasCKaragiozisHResauL. Reliability of the Blessed Telephone Information-Memory-Concentration Test. J Geriatr Psychiatry Neurol1995;8:238242.

    • Search Google Scholar
    • Export Citation
  • 104

    NasreddineZSPhillipsNABedirianV. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc2005;53:695699.

    • Search Google Scholar
    • Export Citation
  • 105

    OlsonRAChhanabhaiTMcKenzieM. Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases. Support Care Cancer2008;16:12731278.

    • Search Google Scholar
    • Export Citation
  • 106

    OlsonRAIversonGLCarolanH. Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life. J Neurooncol2011;105:337344.

    • Search Google Scholar
    • Export Citation
  • 107

    SchneiderLSDagermanKSInselP. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA2005;294:19341943.

    • Search Google Scholar
    • Export Citation
  • 108

    KalesHCValensteinMKimHM. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry2007;164:15681576; quiz 1623.

    • Search Google Scholar
    • Export Citation
  • 109

    RochonPANormandSLGomesT. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med2008;168:10901096.

    • Search Google Scholar
    • Export Citation
  • 110

    BushSHBrueraE. The assessment and management of delirium in cancer patients. Oncologist2009;14:10391049.

  • 111

    InouyeSK. Delirium in older persons. N Engl J Med2006;354:11571165.

  • 112

    InouyeSKvan DyckCHAlessiCA. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med1990;113:941948.

    • Search Google Scholar
    • Export Citation
  • 113

    WeiLAFearingMASternbergEJInouyeSK. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc2008;56:823830.

    • Search Google Scholar
    • Export Citation
  • 114

    LawlorPGNekolaichukCGagnonB. Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: assessing delirium in advanced cancer. Cancer2000;88:28592867.

    • Search Google Scholar
    • Export Citation
  • 115

    GaudreauJDGagnonPHarelF. Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manage2005;29:368375.

    • Search Google Scholar
    • Export Citation
  • 116

    GaudreauJDGagnonPHarelF. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol2005;23:67126718.

    • Search Google Scholar
    • Export Citation
  • 117

    GaudreauJDGagnonPRoyMA. Opioid medications and longitudinal risk of delirium in hospitalized cancer patients. Cancer2007;109:23652373.

    • Search Google Scholar
    • Export Citation
  • 118

    YesavageJABrinkTLRoseTL. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res1982;17:3749.

    • Search Google Scholar
    • Export Citation
  • 119

    D’AthPKatonaPMullanE. Screening, detection and management of depression in elderly primary care attenders. I: the acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam Pract1994;11:260266.

    • Search Google Scholar
    • Export Citation
  • 120

    JongenelisKPotAMEissesAM. Diagnostic accuracy of the original 30-item and shortened versions of the Geriatric Depression Scale in nursing home patients. Int J Geriatr Psychiatry2005;20:10671074.

    • Search Google Scholar
    • Export Citation
  • 121

    JacobsenPB. Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr2004:9397.

  • 122

    JacobsenPBDonovanKAWeitznerMA. Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry2003;8:229240.

    • Search Google Scholar
    • Export Citation
  • 123

    RespiniDJacobsenPBThorsC. The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol2003;47:273279.

  • 124

    HurriaALiDHansenK. Distress in older patients with cancer. J Clin Oncol2009;27:43464351.

  • 125

    ZaboraJBrintzenhofeSzocKJacobsenP. A new psychosocial screening instrument for use with cancer patients. Psychosomatics2001;42:241246.

    • Search Google Scholar
    • Export Citation
  • 126

    ZigmondASSnaithRP. The hospital anxiety and depression scale. Acta Psychiatr Scand1983;67:361370.

  • 127

    MitchellAJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol2007;25:46704681.

    • Search Google Scholar
    • Export Citation
  • 128

    HoffmanBMZevonMAD’ArrigoMCCecchiniTB. Screening for distress in cancer patients: the NCCN rapid-screening measure. Psychooncology2004;13:792799.

    • Search Google Scholar
    • Export Citation
  • 129

    JacobsenPBDonovanKATraskPC. Screening for psychologic distress in ambulatory cancer patients. Cancer2005;103:14941502.

  • 130

    HamermanD. Toward an understanding of frailty. Ann Intern Med1999;130:945950.

  • 131

    FriedLPTangenCMWalstonJ. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci2001;56:M146156.

  • 132

    RaoACohenHJ. Symptom management in the elderly cancer patient: fatigue, pain, and depression. J Natl Cancer Inst Monogr2004:150157.

  • 133

    MintonOStrasserFRadbruchLStoneP. Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European Palliative Care Research Collaborative computerized symptom assessment data set. J Pain Symptom Managein press.

    • Search Google Scholar
    • Export Citation
  • 134

    DemetriGDKrisMWadeJ. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol1998;16:34123425.

    • Search Google Scholar
    • Export Citation
  • 135

    VogelzangNJBreitbartWCellaD. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol1997;34:412.

    • Search Google Scholar
    • Export Citation
  • 136

    BergerAMFarrL. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol Nurs Forum1999;26:16631671.

    • Search Google Scholar
    • Export Citation
  • 137

    HardySEStudenskiSA. Fatigue and function over 3 years among older adults. J Gerontol A Biol Sci Med Sci2008;63:13891392.

  • 138

    LucianiAJacobsenPBExtermannM. Fatigue and functional dependence in older cancer patients. Am J Clin Oncol2008;31:424430.

  • 139

    RaoSS. Prevention of falls in older patients. Am Fam Physician2005;72:8188.

  • 140

    StoneCLawlorPGNolanBKennyRA. A prospective study of the incidence of falls in patients with advanced cancer. J Pain Symptom Manage2011;42:535540.

    • Search Google Scholar
    • Export Citation
  • 141

    ChangJTMortonSCRubensteinLZ. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ2004;328:680680.

    • Search Google Scholar
    • Export Citation
  • 142

    Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc2011;59:148157.

    • Search Google Scholar
    • Export Citation
  • 143

    BalducciL. Bone complications of cancer treatment in the elderly. Oncology (Williston Park)2010;24:741747.

  • 144

    GralowJRBiermannJSFarookiA. NCCN Task Force Report: bone health in cancer care. J Natl Compr Canc Netw2009;7(Suppl 3):S132; quiz S33–35.

    • Search Google Scholar
    • Export Citation
  • 145

    SessumsLLZembrzuskaHJacksonJL. Does this patient have medical decision-making capacity?JAMA2011;306:420427.

  • 146

    HarringtonSESmithTJ. The role of chemotherapy at the end of life: “when is enough, enough?”JAMA2008;299:26672678.

  • 147

    BalducciLExtermannM. Cancer and aging. An evolving panorama. Hematol Oncol Clin North Am2000;14:116.

  • 148

    MonfardiniSFerrucciLFratinoL. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer1996;77:395401.

    • Search Google Scholar
    • Export Citation
  • 149

    RameshHPopeDGennariRAudisioR. Optimising surgical management of elderly cancer patients. World J Surg Oncol2005;3:17.

  • 150

    AudisioRABozzettiFGennariR. The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer2004;40:926938.

    • Search Google Scholar
    • Export Citation
  • 151

    AudisioRARameshHLongoWE. Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist2005;10:262268.

  • 152

    PopeDRameshHGennariR. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol2006;15:189197.

    • Search Google Scholar
    • Export Citation
  • 153

    AudisioRAPopeDRameshHS. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol2008;65:156163.

    • Search Google Scholar
    • Export Citation
  • 154

    ZachariahBBalducciL. Radiation therapy of the older patient. Hematol Oncol Clin North Am2000;14:131167.

  • 155

    DonatoVValerianiMZurloA. Short course radiation therapy for elderly cancer patients. Evidences from the literature review. Crit Rev Oncol Hematol2003;45:305311.

    • Search Google Scholar
    • Export Citation
  • 156

    MitsuhashiNHayakawaKYamakawaM. Cancer in patients aged 90 years or older: radiation therapy. Radiology1999;211:829833.

  • 157

    WasilTLichtmanSMGuptaVRushS. Radiation therapy in cancer patients 80 years of age and older. Am J Clin Oncol2000;23:526530.

  • 158

    ZachariahBBalducciLVenkattaramanabalajiGV. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys1997;39:11251129.

    • Search Google Scholar
    • Export Citation
  • 159

    GelmanRSTaylorSG. Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance. J Clin Oncol1984;2:14041413.

    • Search Google Scholar
    • Export Citation
  • 160

    IbrahimNKFryeDKBuzdarAU. Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome. Arch Intern Med1996;156:882888.

    • Search Google Scholar
    • Export Citation
  • 161

    Giovanazzi-BannonSRademakerALaiGBensonAB. Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study. J Clin Oncol1994;12:24472452.

    • Search Google Scholar
    • Export Citation
  • 162

    NewcombPACarbonePP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst1993;85:15801584.

  • 163

    LichtmanSMWildiersHChatelutE. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients—an analysis of the medical literature. J Clin Oncol2007;25:18321843.

    • Search Google Scholar
    • Export Citation
  • 164

    BalducciLCorcoranMB. Antineoplastic chemotherapy of the older cancer patient. Hematol Oncol Clin North Am2000;14:193212.

  • 165

    HurriaALichtmanSM. Clinical pharmacology of cancer therapies in older adults. Br J Cancer2008;98:517522.

  • 166

    ExtermannMBonettiMSledgeGW. MAX2—a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer2004;40:11931198.

    • Search Google Scholar
    • Export Citation
  • 167

    ShayneMCrawfordJDaleDC. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat2006;100:255262.

    • Search Google Scholar
    • Export Citation
  • 168

    ExtermannMBolerIReichR. The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score: design and validation [abstract]. J Clin Oncol2010;28(Suppl 15):Abstract 9000.

    • Search Google Scholar
    • Export Citation
  • 169

    HurriaATogawaKMohileSG. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol2011;29:34573465.

    • Search Google Scholar
    • Export Citation
  • 170

    JelliffeRWJelliffeSM. Estimation of creatinine clearance from changing serum-creatinine levels. Lancet1971;2:710.

  • 171

    MaloneyKWKaganSH. Adherence and oral agents with older patients. Semin Oncol Nurs2011;27:154160.

  • 172

    DemissieSSillimanRALashTL. Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol2001;19:322328.

    • Search Google Scholar
    • Export Citation
  • 173

    FinkAKGurwitzJRakowskiW. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor—positive breast cancer. J Clin Oncol2004;22:33093315.

    • Search Google Scholar
    • Export Citation
  • 174

    OwusuCBuistDSFieldTS. Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol2008;26:549555.

    • Search Google Scholar
    • Export Citation
  • 175

    PartridgeAHArcherLKornblithAB. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol2010;28:24182422.

    • Search Google Scholar
    • Export Citation
  • 176

    HershmanDLShaoTKushiLH. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat2011;126:529537.

    • Search Google Scholar
    • Export Citation
  • 177

    FloydJDNguyenDTLobinsRL. Cardiotoxicity of cancer therapy. J Clin Oncol2005;23:76857696.

  • 178

    HershmanDLMcBrideRBEisenbergerA. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin’s lymphoma. J Clin Oncol2008;26:31593165.

    • Search Google Scholar
    • Export Citation
  • 179

    AaproMBernard-MartyCBrainEGC. Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Ann Oncol2011;22:257267.

    • Search Google Scholar
    • Export Citation
  • 180

    SuterTMProcterMvan VeldhuisenDJ. Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol2007;25:38593865.

    • Search Google Scholar
    • Export Citation
  • 181

    Tan-ChiuEYothersGRomondE. Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol2005;23:78117819.

    • Search Google Scholar
    • Export Citation
  • 182

    PerezEASumanVJDavidsonNE. Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol2008;26:12311238.

    • Search Google Scholar
    • Export Citation
  • 183

    ProcterMSuterTMde AzambujaE. Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. J Clin Oncol2010;28:34223428.

    • Search Google Scholar
    • Export Citation
  • 184

    RussellSDBlackwellKLLawrenceJ. Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trials. J Clin Oncol2010;28:34163421.

    • Search Google Scholar
    • Export Citation
  • 185

    SerranoCCortesJDe Mattos-ArrudaL. Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors. Ann Oncolin press.

    • Search Google Scholar
    • Export Citation
  • 186

    SlamonDEiermannWRobertN. Phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC→T) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in her2neu positive early breast cancer patients: BCIRG 006 study [abstract]. Presented at the 2009 San Antionio Breast Cancer Symposium; December 9–13, 2009; San Antonio, Texas. Abstract 62.

    • Search Google Scholar
    • Export Citation
  • 187

    ValeroVForbesJPegramMD. Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active therapeutic regimens. J Clin Oncol2011;29:149156.

    • Search Google Scholar
    • Export Citation
  • 188

    JonesSHolmesFAO’ShaughnessyJ. Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US Oncology Research Trial 9735. J Clin Oncol2009;27:11771183.

    • Search Google Scholar
    • Export Citation
  • 189

    SwainSMWhaleyFSGerberMC. Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy. J Clin Oncol1997;15:13331340.

    • Search Google Scholar
    • Export Citation
  • 190

    SwainSMWhaleyFSGerberMC. Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. J Clin Oncol1997;15:13181332.

    • Search Google Scholar
    • Export Citation
  • 191

    MartyMEspieMLlombartA. Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy. Ann Oncol2006;17:614622.

    • Search Google Scholar
    • Export Citation
  • 192

    Launay-VacherVChatelutELichtmanSM. Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations. Ann Oncol2007;18:13141321.

    • Search Google Scholar
    • Export Citation
  • 193

    SulJKDeangelisLM. Neurologic complications of cancer chemotherapy. Semin Oncol2006;33:324332.

  • 194

    ChesonBDVenaDAFossFMSorensenJM. Neurotoxicity of purine analogs: a review. J Clin Oncol1994;12:22162228.

  • 195

    SmithGADamonLERugoHS. High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency. J Clin Oncol1997;15:833839.

    • Search Google Scholar
    • Export Citation
  • 196

    RubinEHAndersenJWBergDT. Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia. J Clin Oncol1992;10:948953.

    • Search Google Scholar
    • Export Citation
  • 197

    BalducciLRepettoL. Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma. Cancer2004;100:611.

  • 198

    BeggCBCarbonePP. Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer1983;52:19861992.

    • Search Google Scholar
    • Export Citation
  • 199

    CrivellariD. Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group. Tumori2002;88(1 Suppl 1):S8182.

    • Search Google Scholar
    • Export Citation
  • 200

    LangerCJManolaJBernardoP. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst2002;94:173181.

    • Search Google Scholar
    • Export Citation
  • 201

    Rocha LimaCMHerndonJE>IIKostyM. Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B. Cancer2002;94:181187.

    • Search Google Scholar
    • Export Citation
  • 202

    NeubauerMSchwartzJCaracandasJ. Results of a phase II study of weekly paclitaxel plus carboplatin in patients with extensive small-cell lung cancer with Eastern Cooperative Oncology Group performance status of 2, or age > or = 70 years. J Clin Oncol2004;22:18721877.

    • Search Google Scholar
    • Export Citation
  • 203

    DoorduijnJKvan der HoltBvan ImhoffGW. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin’s lymphoma. J Clin Oncol2003;21:30413050.

    • Search Google Scholar
    • Export Citation
  • 204

    OsbyEHagbergHKvaloyS. CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. Blood2003;101:38403848.

    • Search Google Scholar
    • Export Citation
  • 205

    ZinzaniPLPavoneEStortiS. Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin’s lymphoma. Blood1997;89:39743979.

    • Search Google Scholar
    • Export Citation
  • 206

    ArmitageJOPotterJF. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly: increased complications with advancing age. J Am Geriatr Soc1984;32:269273.

    • Search Google Scholar
    • Export Citation
  • 207

    BastionYBlayJYDivineM. Elderly patients with aggressive non-Hodgkin’s lymphoma: disease presentation, response to treatment, and survival—a Groupe d’Etude des Lymphomes de l’Adulte study on 453 patients older than 69 years. J Clin Oncol1997;15:29452953.

    • Search Google Scholar
    • Export Citation
  • 208

    BertiniMFreiloneRVitoloU. The treatment of elderly patients with aggressive non-Hodgkin’s lymphomas: feasibility and efficacy of an intensive multidrug regimen. Leuk Lymphoma1996;22:483493.

    • Search Google Scholar
    • Export Citation
  • 209

    GomezHMasLCasanovaL. Elderly patients with aggressive non-Hodgkin’s lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity. J Clin Oncol1998;16:23522358.

    • Search Google Scholar
    • Export Citation
  • 210

    O’ReillySEConnorsJMHowdleS. In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy. J Clin Oncol1993;11:22502257.

    • Search Google Scholar
    • Export Citation
  • 211

    SonneveldPde RidderMvan der LelieH. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin’s lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol1995;13:25302539.

    • Search Google Scholar
    • Export Citation
  • 212

    AmadoriSSuciuSJehnU. Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study. Blood2005;106:2734.

    • Search Google Scholar
    • Export Citation
  • 213

    LowenbergBvan PuttenWTheobaldM. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med2003;349:743752.

    • Search Google Scholar
    • Export Citation
  • 214

    LymanGHKudererNMDjulbegovicB. Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis. Am J Med2002;112:406411.

    • Search Google Scholar
    • Export Citation
  • 215

    RellingMVBoyettJMBlancoJG. Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment. Blood2003;101:38623867.

    • Search Google Scholar
    • Export Citation
  • 216

    PattDADuanZFangS. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. J Clin Oncol2007;25:38713876.

    • Search Google Scholar
    • Export Citation
  • 217

    LymanGHKudererNAgboolaOBalducciL. Evidence-based use of colony-stimulating factors in elderly cancer patients. Cancer Control2003;10:487499.

    • Search Google Scholar
    • Export Citation
  • 218

    RepettoLBiganzoliLKoehneCH. EORTC cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer2003;39:22642272.

    • Search Google Scholar
    • Export Citation
  • 219

    PierelliLPerilloAGreggiS. Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison. J Clin Oncol1999;17:12881296.

    • Search Google Scholar
    • Export Citation
  • 220

    MetivierFMarchaisSJGuerinAP. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant2000;15(Suppl 3):1418.

    • Search Google Scholar
    • Export Citation
  • 221

    PickettJLThebergeDCBrownWS. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis1999;33:11221130.

  • 222

    SilverbergDSWexlerDBlumM. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol2000;35:17371744.

    • Search Google Scholar
    • Export Citation
  • 223

    WuWCRathoreSSWangY. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med2001;345:12301236.

  • 224

    BohliusJWilsonJSeidenfeldJ. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst2006;98:708714.

    • Search Google Scholar
    • Export Citation
  • 225

    JunejaVKeeganPGootenbergJE. Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer. Clin Cancer Res2008;14:32423247.

    • Search Google Scholar
    • Export Citation
  • 226

    BennettCLSilverSMDjulbegovicB. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA2008;299:914924.

    • Search Google Scholar
    • Export Citation
  • 227

    TeplerIEliasLSmithJW. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood1996;87:36073614.

    • Search Google Scholar
    • Export Citation
  • 228

    Vadhan-RajS. Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents. Semin Hematol2009;46:S2632.

    • Search Google Scholar
    • Export Citation
  • 229

    BensonABAjaniJACatalanoRB. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol2004;22:29182926.

    • Search Google Scholar
    • Export Citation
  • 230

    RubensteinEBPetersonDESchubertM. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer2004;100:20262046.

    • Search Google Scholar
    • Export Citation
  • 231

    BensingerWSchubertMAngKK. NCCN Task Force Report: prevention and management of mucositis in cancer care. J Natl Compr Canc Netw2008;6(Suppl 1):121.

    • Search Google Scholar
    • Export Citation
  • 232

    SpielbergerRStiffPBensingerW. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med2004;351:25902598.

    • Search Google Scholar
    • Export Citation
  • 233

    RosenLSAbdiEDavisID. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol2006;24:51945200.

    • Search Google Scholar
    • Export Citation
  • 234

    PetersonDEJonesJBPetitRG. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer2007;109:322331.

    • Search Google Scholar
    • Export Citation
  • 235

    GonsalvesWGantiAK. Targeted anti-cancer therapy in the elderly. Crit Rev Oncol Hematol2011;78:227242.

  • 236

    SekeresMA. Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives. Haematologica2008;93:17691772.

    • Search Google Scholar
    • Export Citation
  • 237

    JoudiFNSmithBJO’DonnellMAKonetyBR. The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy. J Urol2006;175:16341639.

    • Search Google Scholar
    • Export Citation
  • 238

    HerrHW. Age and outcome of superficial bladder cancer treated with bacille Calmette-Guerin therapy. Urology2007;70:6568.

  • 239

    ChamieKHuBDevere WhiteRWEllisonLM. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?BJU Int2008;102:284290.

    • Search Google Scholar
    • Export Citation
  • 240

    GrossmanHBNataleRBTangenCM. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med2003;349:859866.

    • Search Google Scholar
    • Export Citation
  • 241

    DiabSGElledgeRMClarkGM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst2000;92:550556.

    • Search Google Scholar
    • Export Citation
  • 242

    Eppenberger-CastoriSMooreDHJrThorAD. Age-associated biomarker profiles of human breast cancer. Int J Biochem Cell Biol2002;34:13181330.

    • Search Google Scholar
    • Export Citation
  • 243

    BouchardyCRapitiEFiorettaG. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol2003;21:35803587.

    • Search Google Scholar
    • Export Citation
  • 244

    YoodMUOwusuCBuistDSM. Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg2008;206:6675.

  • 245

    SchonbergMAMarcantonioERLiD. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol2010;28:20382045.

    • Search Google Scholar
    • Export Citation
  • 246

    GiulianoAEHuntKKBallmanKV. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA2011;305:569575.

    • Search Google Scholar
    • Export Citation
  • 247

    RudenstamCMZahriehDForbesJF. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol2006;24:337344.

    • Search Google Scholar
    • Export Citation
  • 248

    MartelliGMiceliRDaidoneMG. Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol2011;18:125133.

    • Search Google Scholar
    • Export Citation
  • 249

    HughesKSSchnaperLABerryD. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med2004;351:971977.

    • Search Google Scholar
    • Export Citation
  • 250

    HughesKSSchnaperLACirrincioneC. Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer [abstract]. J Clin Oncol2010;28(Suppl 15):Abstract 507.

    • Search Google Scholar
    • Export Citation
  • 251

    MussHBWoolfSBerryD. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA2005;293:10731081.

  • 252

    MussHBBerryDACirrincioneCT. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med2009;360:20552065.

  • 253

    Piccart-GebhartMJProcterMLeyland-JonesB. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med2005;353:16591672.

    • Search Google Scholar
    • Export Citation
  • 254

    RomondEHPerezEABryantJ. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med2005;353:16731684.

    • Search Google Scholar
    • Export Citation
  • 255

    VuorinenVHinkkaSFarkkilaMJaaskelainenJ. Debulking or biopsy of malignant glioma in elderly people. A randomized study. Acta Neurochir2003;145:510.

    • Search Google Scholar
    • Export Citation
  • 256

    MartinezRJankaMSoldnerFBehrR. Gross total resection of malignant glioma in elderly patients: implications in survival. Zentrabl Neurchir2007;68:176181.

    • Search Google Scholar
    • Export Citation
  • 257

    ScottJSuhJElsonP. Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol2011;13:428436.

    • Search Google Scholar
    • Export Citation
  • 258

    RoaWBrasherPMBaumanG. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized trial. J Clin Oncol2004;22:15831588.

    • Search Google Scholar
    • Export Citation
  • 259

    Keime-GuibertFChinotOTaillandierL. Radiotherapy for glioblastoma in the elderly. N Engl J Med2007;356:15271535.

  • 260

    StuppRHegiMMasonW. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol2009;10:459466.

    • Search Google Scholar
    • Export Citation
  • 261

    LanzettaGMinnitiG. Treatment of glioblastoma in elderly patients: an overview of current treatments and future perspective. Tumori2010;96:650658.

    • Search Google Scholar
    • Export Citation
  • 262

    NghiemphuPLLiuWLeeY. Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience. Neurology2009;72:12171222.

    • Search Google Scholar
    • Export Citation
  • 263

    GavrilovicIHormigoAYahalomJ. Long term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol2006;24:45704574.

    • Search Google Scholar
    • Export Citation
  • 264

    NeyDEReinerASPanageasKS. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Cancer2010;116:46054612.

    • Search Google Scholar
    • Export Citation
  • 265

    ZhuJJGerstnerEREnglerDA. High-dose methotrexate for elderly patients with primary CNS lymphoma. Neuro Oncol2009;11:211215.

  • 266

    SchiffmannLOzcanSSchwarzF. Colorectal cancer in the elderly: surgical treatment and long-term survival. Int J Colorectal Dis2008;23:601610.

    • Search Google Scholar
    • Export Citation
  • 267

    DevonKMVergara-FernandezOVictorJCMcLeodRS. Colorectal cancer surgery in elderly patients: presentation, treatment, and outcomes. Dis Colon Rectum2009;52:12721277.

    • Search Google Scholar
    • Export Citation
  • 268

    OngESAlassasMDunnKBRajputA. Colorectal cancer surgery in the elderly: acceptable morbidity?Am J Surg2008;195:344348.

  • 269

    AdamRFrillingAEliasD. Liver resection of colorectal metastases in elderly patients. Br J Surg2010;97:366376.

  • 270

    SchragDCramerLDBachPBBeggCB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst2001;93:850857.

    • Search Google Scholar
    • Export Citation
  • 271

    Jackson McClearyNAMeyerhardtJGreenE. Impact of older age on the efficacy of newer adjuvant therapies in >12,500 patients (pts) with stage II/III colon cancer: findings from the ACCENT Database. J Clin Oncol2009;27:4010.

    • Search Google Scholar
    • Export Citation
  • 272

    FolprechtGCunninghamDRossP. Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol2004;15:13301338.

    • Search Google Scholar
    • Export Citation
  • 273

    SeymourMTThompsonLCWasanHS. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. Lancet2011;377:17491759.

    • Search Google Scholar
    • Export Citation
  • 274

    FigerAPerez-StaubNCarolaE. FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer2007;110:26662671.

    • Search Google Scholar
    • Export Citation
  • 275

    CassidyJSaltzLBGiantonioBJ. Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies. J Cancer Res Clin Oncol2010;136:737743.

    • Search Google Scholar
    • Export Citation
  • 276

    KozloffMFBerlinJFlynnPJ. Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study. Oncology2010;78:329339.

    • Search Google Scholar
    • Export Citation
  • 277

    BouchahdaMMacarullaTSpanoJP. Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer. Crit Rev Oncol Hematol2008;67:255262.

    • Search Google Scholar
    • Export Citation
  • 278

    FornaroLBaldiGGMasiG. Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational status. Crit Rev Oncol Hematol2011;78:243251.

    • Search Google Scholar
    • Export Citation
  • 279

    SastreJArandaEGravalosC. First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD). Crit Rev Oncol Hematol2011;77:7884.

    • Search Google Scholar
    • Export Citation
  • 280

    Van CutsemEPeetersMSienaS. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol2007;25:16581664.

    • Search Google Scholar
    • Export Citation
  • 281

    AmadoRGWolfMPeetersM. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol2008;26:16261634.

    • Search Google Scholar
    • Export Citation
  • 282

    ZabrodskyMCalabreseLTosoniA. Major surgery in elderly head and neck cancer patients: immediate and long-term surgical results and complication rates. Surg Oncol2004;13:249255.

    • Search Google Scholar
    • Export Citation
  • 283

    PignonTHoriotJCVan den BogaertW. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer1996;32A:20752081.

  • 284

    PosnerMRHershockDMBlajmanCR. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med2007;357:17051715.

    • Search Google Scholar
    • Export Citation
  • 285

    VermorkenJBRemenarEvan HerpenC. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med2007;357:16951704.

    • Search Google Scholar
    • Export Citation
  • 286

    ForastiereAAGoepfertHMaorM. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med2003;349:20912098.

    • Search Google Scholar
    • Export Citation
  • 287

    PignonJPle MaitreAMaillardEBourhisJ. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol2009;92:414.

    • Search Google Scholar
    • Export Citation
  • 288

    MachtayMMoughanJTrottiA. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol2008;26:35823589.

    • Search Google Scholar
    • Export Citation
  • 289

    ArgirisALiYMurphyBA. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol2004;22:262268.

    • Search Google Scholar
    • Export Citation
  • 290

    BonnerJAHarariPMGiraltJ. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol2010;11:2128.

    • Search Google Scholar
    • Export Citation
  • 291

    VermorkenJBMesiaRRiveraF. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med2008;359:11161127.

  • 292

    LaneBRAbouassalyRGaoT. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer2010;116:31193126.

    • Search Google Scholar
    • Export Citation
  • 293

    BajettaERavaudABracardaS. Efficacy and safety of first-line bevacizumab (BEV) plus interferon-{alpha}2a (IFN) in patients (pts) >=65 years with metastatic renal cell carcinoma (mRCC) [abstract]. J Clin Oncol2008;26(Suppl 15):Abstract 5095.

    • Search Google Scholar
    • Export Citation
  • 294

    EisenTOudardSSzczylikC. Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial. J Natl Cancer Inst2008;100:14541463.

    • Search Google Scholar
    • Export Citation
  • 295

    BukowskiRMStadlerWMMcDermottDF. Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program. Oncology2010;78:340347.

    • Search Google Scholar
    • Export Citation
  • 296

    GoreMESzczylikCPortaC. Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial. Lancet Oncol2009;10:757763.

    • Search Google Scholar
    • Export Citation
  • 297

    HutsonTEBukowskiRMRiniBI. A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC) [abstract]. J Clin Oncol2011;29(Supp1):Abstract 4604.

    • Search Google Scholar
    • Export Citation
  • 298

    OsantoSHutsonTECalvoE. Efficacy and safety of everolimus in elderly patients (pts) with metastatic renal cell carcinoma (mRCC) [abstract]. J Clin Oncol2010;28(Suppl 15):Abstract 4608.

    • Search Google Scholar
    • Export Citation
  • 299

    HudesGCarducciMTomczakP. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med2007;356:22712281.

  • 300

    PalumboABringhenSCaravitaT. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. Lancet2006;367:825831.

    • Search Google Scholar
    • Export Citation
  • 301

    PalumboABringhenSLiberatiAM. Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial. Blood2008;112:31073114.

    • Search Google Scholar
    • Export Citation
  • 302

    FaconTMaryJYHulinC. Melphalan and predn